Ben Ho Park, MD, PhD, is Director of the Vanderbilt-Ingram Cancer Center (VICC). Dr. Park is also a Professor of Medicine in the Department of Medicine's Division of Hematology and Oncology.

Dr. Park's research is dedicated to finding a cure for all types of breast cancer by investigating mutated and altered genes responsible for the development and progression of breast cancer, as well as genes that lead to drug resistance. He is actively involved with the VICC Breast Cancer Research Program’s clinical research team to translate his research into clinical practice and patient care.

Dr. Park received his undergraduate degree with honors from the University of Chicago in 1989. He then completed a dual M.D., Ph.D. training program at the University of Pennsylvania School of Medicine in 1995. Dr. Park completed a residency in Internal Medicine and Hematology/Oncology Fellowship training at the Hospital of the University of Pennsylvania. In 2001, Dr. Park finished a postdoctoral research fellowship in cancer genetics in the laboratory of Dr. Bert Vogelstein at Johns Hopkins. In 2002, Dr. Park joined the faculty in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and held several positions including Associate Dean for Postdoctoral Affairs for the School of Medicine and Associate Director for Research Training and Education for the Johns Hopkins Cancer Center. Dr. Park joined Vanderbilt University Medical Center/Vanderbilt University in 2018.